First Results from the REAL AD Study Presented at the CTAD Conference in Madrid
November 4, 2024
At the CTAD (Clinical Trials on Alzheimer's Disease) conference in Madrid, held from October 29 to November 1, 2024, the study leader, Professor Michael Schöll, presented the first results from the REAL AD study.
Professor Schöll introduced the study to the scientific community and shared insights into the study's progress, including the very first results such as demographic data from the research group and the initial outcomes from cognitive tests. In just 6 months, the study has successfully recruited over 5,000 participants. We are extremely grateful for the invaluable contribution of all our participants. The presentation was well-received by researchers and experts in the field and marked an important milestone in the study's development.
Data is continuously being collected and will lead to more detailed analyses in 2025. Once the first results are published, we will be happy to share the article with you here.